434 related articles for article (PubMed ID: 11785696)
1. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix.
Woo BH; Fink BF; Page R; Schrier JA; Jo YW; Jiang G; DeLuca M; Vasconez HC; DeLuca PP
Pharm Res; 2001 Dec; 18(12):1747-53. PubMed ID: 11785696
[TBL] [Abstract][Full Text] [Related]
2. Two lyophilized polymer matrix recombinant human bone morphogenetic protein-2 carriers in rabbit calvarial defects.
Rodgers JB; Vasconez HC; Wells MD; DeLuca PP; Faugere MC; Fink BF; Hamilton D
J Craniofac Surg; 1998 Mar; 9(2):147-53. PubMed ID: 9586544
[TBL] [Abstract][Full Text] [Related]
3. Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2.
Kim SS; Gwak SJ; Kim BS
J Biomed Mater Res A; 2008 Oct; 87(1):245-53. PubMed ID: 18181112
[TBL] [Abstract][Full Text] [Related]
4. Effect of a freeze-dried CMC/PLGA microsphere matrix of rhBMP-2 on bone healing.
Schrier JA; Fink BF; Rodgers JB; Vasconez HC; DeLuca PP
AAPS PharmSciTech; 2001 Oct; 2(3):E18. PubMed ID: 14727877
[TBL] [Abstract][Full Text] [Related]
5. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering.
Kempen DH; Lu L; Hefferan TE; Creemers LB; Maran A; Classic KL; Dhert WJ; Yaszemski MJ
Biomaterials; 2008 Aug; 29(22):3245-52. PubMed ID: 18472153
[TBL] [Abstract][Full Text] [Related]
6. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.
Qiao C; Zhang K; Jin H; Miao L; Shi C; Liu X; Yuan A; Liu J; Li D; Zheng C; Zhang G; Li X; Yang B; Sun H
Int J Nanomedicine; 2013; 8():2985-95. PubMed ID: 23990717
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects.
Oest ME; Dupont KM; Kong HJ; Mooney DJ; Guldberg RE
J Orthop Res; 2007 Jul; 25(7):941-50. PubMed ID: 17415756
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer.
Heckman JD; Ehler W; Brooks BP; Aufdemorte TB; Lohmann CH; Morgan T; Boyan BD
J Bone Joint Surg Am; 1999 Dec; 81(12):1717-29. PubMed ID: 10608383
[TBL] [Abstract][Full Text] [Related]
10. Depot injectable biodegradable nanoparticles loaded with recombinant human bone morphogenetic protein-2: preparation, characterization, and in vivo evaluation.
Hassan AH; Hosny KM; Murshid ZA; Alhadlaq A; Alyamani A; Naguib G
Drug Des Devel Ther; 2015; 9():3599-606. PubMed ID: 26203226
[TBL] [Abstract][Full Text] [Related]
11. Repair of an osteochondral defect by sustained delivery of BMP-2 or TGFβ1 from a bilayered alginate-PLGA scaffold.
Reyes R; Delgado A; Sánchez E; Fernández A; Hernández A; Evora C
J Tissue Eng Regen Med; 2014 Jul; 8(7):521-33. PubMed ID: 22733683
[TBL] [Abstract][Full Text] [Related]
12. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo.
Boyan BD; Lohmann CH; Somers A; Niederauer GG; Wozney JM; Dean DD; Carnes DL; Schwartz Z
J Biomed Mater Res; 1999 Jul; 46(1):51-9. PubMed ID: 10357135
[TBL] [Abstract][Full Text] [Related]
13. Sustained delivery of rhBMP-2 by means of poly(lactic-co-glycolic acid) microspheres: cranial bone regeneration without heterotopic ossification or craniosynostosis.
Wink JD; Gerety PA; Sherif RD; Lim Y; Clarke NA; Rajapakse CS; Nah HD; Taylor JA
Plast Reconstr Surg; 2014 Jul; 134(1):51-59. PubMed ID: 24622573
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
[TBL] [Abstract][Full Text] [Related]
15. Regeneration of calvarial defects with Escherichia coli -derived rhBMP-2 adsorbed in PLGA membrane.
Ono M; Sonoyama W; Nema K; Hara ES; Oida Y; Pham HT; Yamamoto K; Hirota K; Sugama K; Sebald W; Kuboki T
Cells Tissues Organs; 2013; 198(5):367-76. PubMed ID: 24434422
[TBL] [Abstract][Full Text] [Related]
16. Chitosan/nHAC/PLGA microsphere vehicle for sustained release of rhBMP-2 and its derived synthetic oligopeptide for bone regeneration.
Ji Y; Wang M; Liu W; Chen C; Cui W; Sun T; Feng Q; Guo X
J Biomed Mater Res A; 2017 Jun; 105(6):1593-1606. PubMed ID: 27862940
[TBL] [Abstract][Full Text] [Related]
17. [Effect of sustained release of recombinant rat insulin-like growth factor-1 from poly (lactide-CO-glycolide ) microspheres on bone formation in the peri-implant areas in Goto-Kakizaki rats with type 2 diabetes].
Yu M; Hui XM; Wang F; Zhang N; Zhang HP; Song YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Jun; 32(3):260-4. PubMed ID: 20602874
[TBL] [Abstract][Full Text] [Related]
18. Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement.
Fei Z; Hu Y; Wu D; Wu H; Lu R; Bai J; Song H
J Mater Sci Mater Med; 2008 Mar; 19(3):1109-16. PubMed ID: 17701313
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer.
Isobe M; Yamazaki Y; Oida S; Ishihara K; Nakabayashi N; Amagasa T
J Biomed Mater Res; 1996 Nov; 32(3):433-8. PubMed ID: 8897149
[TBL] [Abstract][Full Text] [Related]
20. The role of recombinant human bone morphogenetic protein-2 in PLGA capsules at an extraskeletal site of the rat.
Isobe M; Yamazaki Y; Mori M; Ishihara K; Nakabayashi N; Amagasa T
J Biomed Mater Res; 1999 Apr; 45(1):36-41. PubMed ID: 10397955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
